Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FZL18
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,093
Award facts
- Contract value 100% obligated
- $41,093.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $41,093.40 by the Defense Logistics Agency (DLA) on September 18, 2025. The delivery order covers the supply of Xolair 300 mg/2 mL auto-injector units, a prescription biologic medication used to treat moderate-to-severe allergic asthma and other allergic conditions. The contract carries no set-aside designation and requires ultimate completion by October 9, 2025, with performance taking place at the vendor's Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC establishes DMS Pharmaceutical Group as a primary supplier for a comprehensive range of pharmaceutical products supporting the medical supply needs of military healthcare facilities worldwide, including prescription medications, biologics, auto-injectors, and specialty pharmaceuticals. The company has demonstrated consistent success in federal procurement markets, leveraging its woman-owned small business status to secure multiple delivery orders across diverse pharmaceutical product categories for Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FZL18?
SPE2DB25FZL18 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FZL18 worth?
The government has obligated $41,093 on SPE2DB25FZL18.
Is contract SPE2DB25FZL18 an order under another contract?
Yes. SPE2DB25FZL18 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZL18 competed?
The extent of competition for SPE2DB25FZL18 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award